• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Tommy Tuberville Sells Several Large Stock Positions, Makes New Buys: Here's What The US Senator Is Betting On Now

    6/17/24 6:45:29 PM ET
    $CLF
    $HUMA
    $INTC
    $PARA
    Metal Mining
    Basic Materials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $CLF alert in real time by email

    The trading activity of members of Congress continues to draw increased attention from investors with the potential that conflicts of interest, including committee assignments, could influence trades.

    A well-known member of Congress disclosed multiple trades on Friday around market close.

    What Happened: The increased attention on Congress trading activity has led to the creation of several Congress Trading ETFs and a new one on the way.

    Sen. Tommy Tuberville (R-Ala.) is one of the most active traders in Congress and has drawn scrutiny for past trades. The senator's trades often come in large quantities and big amounts.

    On Friday, Tuberville disclosed a large amount of trades with mostly sales of previous positions and the buying of call and put options on new and old positions.

    Some of the larger transactions were the sale of Cleveland-Cliffs Inc (NYSE:CLF) stock, the sale of Intel Corp (NASDAQ:INTC) stock and exiting the position of Humacyte Inc (NASDAQ:HUMA).

    Tuberville also bought calls and puts on the Ark Innovation ETF (NYSE:ARKK).

    The senator also sold shares of media company Paramount Global (NASDAQ:PARA)(NASDAQ:PARAA), which was the subject of a potential merger that fell apart.

    The only buys outside of the options in the latest disclosure were additional Intel shares and a $1,000 to $15,000 position in health care company Solventum Coproration (NYSE:SOLV).

    "Breaking: Senator Tuberville just reported millions of dollars in trades, intentionally on a Friday afternoon to avoid media coverage," Congresstrading tweeted on Friday.

    Related Link: EXCLUSIVE: Khanna Says ‘Shameful’ Congress Members Profited From Stocks, Calls For Trading Ban: ‘Making Money When The Rest Of The Country Was Suffering During The Pandemic’


    Why It's Important: Tuberville sits on several committees in Congress. This has led to increased attention to his trades in stocks such as Humacyte, with his placement on the Armed Services Committee, and transportation and commodity-related stocks with his position on the Senate Committee on Agriculture, Nutrition and Forestry.

    Humacyte drew attention from traders previously as the company has been connected to products being used in Ukraine during the Russia-Ukraine War.

    Earlier this year, a disclosure that Tuberville bought $50,000 to $100,000 in shares of regional bank Southern States Bancshares (NASDAQ:SSBK) drew attention as it was flagged that the bank's CEO had donated to Tuberville's campaign previously.

    Tuberville also previously purchased shares of Intel before the CHIPS Act was signed into law by President Joe Biden. The CHIPS Act gave $50 billion in funding to chip companies, including Intel.

    Representatives for Tuberville told the Montgomery Advertiser previously he has financial advisors who manage his portfolio.

    While some members of Congress have supported a ban on stock and options trading, Tuberville has opposed such a measure in the past, calling it “ridiculous.”

    “I think it would really cut back on the amount of people that would want to come up here and serve, I really do. We don’t need that,” Tuberville told The Independent in 2022.

    Read Next: 10 Best Stock Traders In Congress In 2023 (Spoiler: Nancy Pelosi Has Reentered The Chat)

    Photo: Sen. Tommy Tuberville via Shutterstock

    Get the next $CLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLF
    $HUMA
    $INTC
    $PARA

    CompanyDatePrice TargetRatingAnalyst
    Cleveland-Cliffs Inc.
    $CLF
    4/1/2026$9.00Neutral
    Goldman
    Cleveland-Cliffs Inc.
    $CLF
    3/25/2026Sector Weight
    KeyBanc Capital Markets
    Solventum Corporation
    $SOLV
    3/24/2026$60.00Sell
    Rothschild & Co Redburn
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    Solventum Corporation
    $SOLV
    1/26/2026$97.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Cleveland-Cliffs Inc.
    $CLF
    1/23/2026Buy → Neutral
    Seaport Research Partners
    Solventum Corporation
    $SOLV
    1/20/2026$100.00Neutral → Outperform
    Mizuho
    Intel Corporation
    $INTC
    1/20/2026$50.00Reduce → Hold
    HSBC Securities
    More analyst ratings

    $CLF
    $HUMA
    $INTC
    $PARA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wendell Amy Mcbride bought $100,344 worth of shares (1,475 units at $68.03), increasing direct ownership by 41% to 5,039 units (SEC Form 4)

    4 - Solventum Corp (0001964738) (Issuer)

    3/11/26 6:31:11 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Director Camara Edilson bought $199,626 worth of shares (19,700 units at $10.13), increasing direct ownership by 88% to 41,983 units (SEC Form 4)

    4 - CLEVELAND-CLIFFS INC. (0000764065) (Issuer)

    2/13/26 11:23:21 AM ET
    $CLF
    Metal Mining
    Basic Materials

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    $CLF
    $HUMA
    $INTC
    $PARA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Stoliar Gabriel

    4 - CLEVELAND-CLIFFS INC. (0000764065) (Issuer)

    4/2/26 5:21:38 PM ET
    $CLF
    Metal Mining
    Basic Materials

    SEC Form 4 filed by Cronin Jane M.

    4 - CLEVELAND-CLIFFS INC. (0000764065) (Issuer)

    4/2/26 5:21:31 PM ET
    $CLF
    Metal Mining
    Basic Materials

    SEC Form 4 filed by Bloom Ron A.

    4 - CLEVELAND-CLIFFS INC. (0000764065) (Issuer)

    4/2/26 5:21:23 PM ET
    $CLF
    Metal Mining
    Basic Materials

    $CLF
    $HUMA
    $INTC
    $PARA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cleveland-Cliffs to Announce First-Quarter 2026 Earnings Results and Host Conference Call on April 20

    Cleveland-Cliffs Inc. (NYSE:CLF) will announce first-quarter 2026 earnings results before the U.S. market open on Monday, April 20, 2026. The Company invites interested parties to listen to a live broadcast of a conference call with securities analysts and institutional investors to discuss the results on the same morning, April 20, 2026, at 8:30 am ET. The call can be accessed at www.clevelandcliffs.com and will also be archived and available for replay at that address. About Cleveland-Cliffs Inc. Cleveland-Cliffs is a leading North America-based steel producer with focus on value-added sheet products, particularly for the automotive industry. The Company is vertically integrated fro

    4/2/26 4:15:00 PM ET
    $CLF
    Metal Mining
    Basic Materials

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Intel to Repurchase 49% Equity Interest in Ireland Fab Joint Venture

    Intel Corporation (NASDAQ:INTC) and Apollo (NYSE:APO) today announced a definitive agreement for Intel to repurchase the 49% equity interest in the joint venture related to Intel's Fab 34 in Ireland not held by Intel for $14.2 billion. The agreement reflects Intel's continued business momentum underpinned by the growing and essential role CPUs play in the era of AI, a significantly strengthened balance sheet and the strong partnership between Intel and Apollo. In 2024, Apollo-managed funds and affiliates led an $11.2 billion investment to acquire a 49% equity interest in a joint venture entity related to Fab 34, providing Intel with equity-like capital while preserving balance sheet stren

    4/1/26 9:00:00 AM ET
    $APO
    $INTC
    Investment Managers
    Finance
    Semiconductors
    Technology

    $CLF
    $HUMA
    $INTC
    $PARA
    SEC Filings

    View All

    Intel Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - INTEL CORP (0000050863) (Filer)

    4/3/26 12:50:37 PM ET
    $INTC
    Semiconductors
    Technology

    SEC Form DEFA14A filed by Cleveland-Cliffs Inc.

    DEFA14A - CLEVELAND-CLIFFS INC. (0000764065) (Filer)

    4/2/26 4:56:03 PM ET
    $CLF
    Metal Mining
    Basic Materials

    SEC Form DEF 14A filed by Cleveland-Cliffs Inc.

    DEF 14A - CLEVELAND-CLIFFS INC. (0000764065) (Filer)

    4/2/26 4:54:17 PM ET
    $CLF
    Metal Mining
    Basic Materials

    $CLF
    $HUMA
    $INTC
    $PARA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Cleveland-Cliffs with a new price target

    Goldman initiated coverage of Cleveland-Cliffs with a rating of Neutral and set a new price target of $9.00

    4/1/26 8:34:45 AM ET
    $CLF
    Metal Mining
    Basic Materials

    KeyBanc Capital Markets resumed coverage on Cleveland-Cliffs

    KeyBanc Capital Markets resumed coverage of Cleveland-Cliffs with a rating of Sector Weight

    3/25/26 8:29:13 AM ET
    $CLF
    Metal Mining
    Basic Materials

    Rothschild & Co Redburn initiated coverage on Solventum with a new price target

    Rothschild & Co Redburn initiated coverage of Solventum with a rating of Sell and set a new price target of $60.00

    3/24/26 8:51:05 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $CLF
    $HUMA
    $INTC
    $PARA
    Leadership Updates

    Live Leadership Updates

    View All

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Humacyte Appoints Rick McElheny as Senior Vice President of Business Development

    - Mr. McElheney brings more than 15 of years' experience in corporate development and alliance management at biopharma companies. -  - He will work with the Company's leadership team to expand corporate collaborations to accelerate the development and commercialization of Humacyte's broad pipeline - DURHAM, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has appointed Rick McElheny to the role of Senior Vice President of Business Development. Mr. McElheny will work with the Company's leadership team to expan

    3/26/26 8:00:00 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    $CLF
    $HUMA
    $INTC
    $PARA
    Financials

    Live finance-specific insights

    View All

    Cleveland-Cliffs to Announce First-Quarter 2026 Earnings Results and Host Conference Call on April 20

    Cleveland-Cliffs Inc. (NYSE:CLF) will announce first-quarter 2026 earnings results before the U.S. market open on Monday, April 20, 2026. The Company invites interested parties to listen to a live broadcast of a conference call with securities analysts and institutional investors to discuss the results on the same morning, April 20, 2026, at 8:30 am ET. The call can be accessed at www.clevelandcliffs.com and will also be archived and available for replay at that address. About Cleveland-Cliffs Inc. Cleveland-Cliffs is a leading North America-based steel producer with focus on value-added sheet products, particularly for the automotive industry. The Company is vertically integrated fro

    4/2/26 4:15:00 PM ET
    $CLF
    Metal Mining
    Basic Materials

    Intel to Report First-Quarter 2026 Financial Results

    Intel Corporation today announced that it will report first-quarter financial results on Thursday, April 23, 2026, promptly after close of market. Intel will then hold an earnings conference call at 2 p.m. PT that day to discuss the results. A live public webcast of the earnings conference call can be accessed on Intel's Investor Relations website at intc.com. Associated materials and webcast replay will also be available on the site. About Intel Intel (NASDAQ:INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for ever

    3/31/26 5:02:00 PM ET
    $INTC
    Semiconductors
    Technology

    Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026

    DURHAM, N.C., March 23, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company will release its financial results for the quarter and year ended December 31, 2025 on Friday March 27, 2026. Management will host a webcast and conference call at 8:00 a.m. Eastern Time to provide a corporate and financial update. TitleHumacyte 2025 Fourth Quarter and Year End Financial Results and Corporate UpdateDateMarch 27, 2026Time8:00 a.m. Eastern TimeConference Details1-877-704-4453 (U.S. Investors)1-201-389-0920 (International Investors)1

    3/23/26 8:00:00 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CLF
    $HUMA
    $INTC
    $PARA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Paramount Global

    SC 13D/A - Paramount Global (0000813828) (Subject)

    12/12/24 4:14:51 PM ET
    $PARAA
    Broadcasting
    Industrials

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/20/24 7:10:08 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/18/24 4:10:14 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care